Does exhaled nitric oxide measurement have a role in asthma care?

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 3, 2009, Pages 253-255

  Oppenheimer, John ^a,c   Sorkness, Christine A ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Pulmonary and Allergy Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; HEMOGLOBIN A1C; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; MONTELUKAST; NITRIC OXIDE;

ASTHMA; DAILY LIFE ACTIVITY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; EOSINOPHIL; EXHALATION; EXPIRED AIR; HUMAN; LUNG FUNCTION; MAINTENANCE THERAPY; PH; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SHORT SURVEY; TREATMENT RESPONSE; WAKEFULNESS;

EID: 63449119295     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60089-0     Document Type: Article

References (21)

1. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 2007.
2. GINA Report, Global Strategy for Asthma Management and Prevention 2006. www.ginasthma.com. Accessed December 20, 2008.
3. Li J, Oppenheimer J, Bernstein IL, et al. Attaining optimal asthma control: a practice parameter. J Allergy Clin Immunol. 2005;115:s3-s11.
4. Shingo S, Zhang J, Reiss TF. Correlation of airway obstruction and patient reported endpoints in clinical studies. Eur Respir J. 2001;17: 220-224.
5. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ; The AMPUL Study Group. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med. 1999;159:1043-1051.
6. Green R, Brightling C, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet. 2002; 360:1715-1721.
7. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352:2163-2173.
8. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med. 2007;176:231-237.
9. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner city adolescents and young adults: a randomized controlled trial. Lancet. 2008;372:1065-1072.
10. Franklin PJ, Stick SM. The value of FeNO measurement in asthma management: the motion against F to help manage childhood asthma-reality bites. Paediatr Respir Rev. 2008;9:122-126.
11. Silkoff PE, McClean PA, Slutsky AS, et al. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma. 1998;35:473-479.
12. Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults Am J Respir Crit Care Med. 2007;176:238 -242.
13. Jones ST, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001;164:738 -743.
14. Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER. Is the neutrophil the key effector cell in severe asthma? Thorax. 2005;60:529-530.
15. Szefler SJ, Phillips B, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol. 2005;115:233-242.
16. Knuffman JE, Sorkness CA, Lemanske RF Jr, et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol. In press.
17. van Veen LH, ten Brinke A, Sterk PJ, et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J. 2008; 32:344-349.
18. Wolfe JD, Dreon DM, Parikh BR, Hutchins EE, Bates MN. The predictive power of frequent measurements in patients with asthma. J Allergy Clin Immunol. 2007;119:s81.
19. Buist AS, Vollmer WM, Wilson SR. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med. 2006;174:1077-1087.
20. 20.Čáp P, Chládek J, Pehal F, et al. Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax. 2004;59: 465-470.
21. Hunt JF, Fang K, Malik R, et al. Endogenous airway acidification. Am J Respir Crit Care Med. 2000;161:694-699.